SynopsisThe global African Trypanosomiasis Treatment market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of African Trypanosomiasis Treatment in various end use ind.....
SynopsisThe global Severe Acute Respiratory Syndrome (SARS) Therapeutics market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Severe Acute Respiratory Syndrome (S.....
SynopsisThe global Nasopharyngeal Cancer Drug market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Nasopharyngeal Cancer Drug in various end use industries. The e.....
SynopsisAlpha-1 antitrypsin deficiency (A1AD) is a hereditary disorder characterized by low levels of a protein called alpha-1 antitrypsin (A1AT) which is found in the blood. This deficiency may predispose an individual to several illnesses and most commonly manifests.....
SynopsisThe global C-C Chemokine Receptor Type 5 market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of C-C Chemokine Receptor Type 5 in various end use industries......
SynopsisThe global Metabotropic Glutamate Receptor 2 market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Metabotropic Glutamate Receptor 2 in various end use ind.....
SynopsisThe global Chronic Inflammatory Demyelinating Polyneuropathy Drug market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Chronic Inflammatory Demyelinating .....
SynopsisThe global Trigeminal Neuralgia Therapeutics market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Trigeminal Neuralgia Therapeutics in various end use ind.....
SynopsisThe global Visceral Pain Treatment market size is expected to reach US$ 19220 million by 2029, growing at a CAGR of 5.2% from 2023 to 2029. The market is mainly driven by the significant applications of Visceral Pain Treatment in various end use industries. Th.....
SynopsisThe global Hodgkin Lymphoma Treatment market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Hodgkin Lymphoma Treatment in various end use industries. The e.....








